These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22961545)

  • 1. Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice.
    Kollmann K; Damme M; Markmann S; Morelle W; Schweizer M; Hermans-Borgmeyer I; Röchert AK; Pohl S; Lübke T; Michalski JC; Käkelä R; Walkley SU; Braulke T
    Brain; 2012 Sep; 135(Pt 9):2661-75. PubMed ID: 22961545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural analysis of neuronal and non-neuronal lysosomal storage in mucolipidosis type II knock-in mice.
    Schweizer M; Markmann S; Braulke T; Kollmann K
    Ultrastruct Pathol; 2013 Oct; 37(5):366-72. PubMed ID: 24047352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology.
    Paton L; Bitoun E; Kenyon J; Priestman DA; Oliver PL; Edwards B; Platt FM; Davies KE
    J Biol Chem; 2014 Sep; 289(39):26709-26721. PubMed ID: 25107912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic abnormalities in mouse models of the lysosomal storage disorders mucolipidosis II and mucolipidosis III γ.
    Idol RA; Wozniak DF; Fujiwara H; Yuede CM; Ory DS; Kornfeld S; Vogel P
    PLoS One; 2014; 9(10):e109768. PubMed ID: 25314316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannose 6-phosphate-dependent targeting of lysosomal enzymes is required for normal craniofacial and dental development.
    Koehne T; Markmann S; Schweizer M; Muschol N; Friedrich RE; Hagel C; Glatzel M; Kahl-Nieke B; Amling M; Schinke T; Braulke T
    Biochim Biophys Acta; 2016 Sep; 1862(9):1570-80. PubMed ID: 27239697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucolipidoses II and III variants with normal N-acetylglucosamine 1-phosphotransferase activity toward alpha-methylmannoside are due to nonallelic mutations.
    Ben-Yoseph Y; Mitchell DA; Yager RM; Wei JT; Chen TH; Shih LY
    Am J Hum Genet; 1992 Jan; 50(1):137-44. PubMed ID: 1309624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal Proteome and Secretome Analysis Identifies Missorted Enzymes and Their Nondegraded Substrates in Mucolipidosis III Mouse Cells.
    Di Lorenzo G; Velho RV; Winter D; Thelen M; Ahmadi S; Schweizer M; De Pace R; Cornils K; Yorgan TA; Grüb S; Hermans-Borgmeyer I; Schinke T; Müller-Loennies S; Braulke T; Pohl S
    Mol Cell Proteomics; 2018 Aug; 17(8):1612-1626. PubMed ID: 29773673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha/beta: a case report.
    Ho CC; Tsung LL; Liu KT; Poon WT
    BMC Med Genet; 2018 Sep; 19(1):162. PubMed ID: 30208878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophoretic abnormalities of lysosomal enzymes in mucolipidosis fibroblast lines.
    Champion MJ; Shows TB
    Am J Hum Genet; 1977 Mar; 29(2):149-63. PubMed ID: 848490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition.
    Qian Y; van Meel E; Flanagan-Steet H; Yox A; Steet R; Kornfeld S
    J Biol Chem; 2015 Jan; 290(5):3045-56. PubMed ID: 25505245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme biosynthesis.
    Mueller OT; Honey NK; Little LE; Miller AL; Shows TB
    J Clin Invest; 1983 Sep; 72(3):1016-23. PubMed ID: 6309902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vacuolization of mucolipidosis type II mouse exocrine gland cells represents accumulation of autolysosomes.
    Boonen M; van Meel E; Oorschot V; Klumperman J; Kornfeld S
    Mol Biol Cell; 2011 Apr; 22(8):1135-47. PubMed ID: 21325625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the co-existence of galactosyl and phosphomannosyl residues on beta-hexosaminidase on the processing and transport of the enzyme in mucolipidosis I fibroblasts.
    Vladutiu GD
    Biochim Biophys Acta; 1983 Nov; 760(3):363-70. PubMed ID: 6226317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pathology of murine mucolipidosis types II and IIIC.
    Vogel P; Payne BJ; Read R; Lee WS; Gelfman CM; Kornfeld S
    Vet Pathol; 2009 Mar; 46(2):313-24. PubMed ID: 19261645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of the GlcNac-1-phosphotransferase.
    Braulke T; Pohl S; Storch S
    J Inherit Metab Dis; 2008 Apr; 31(2):253-7. PubMed ID: 18425436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Proteome Analysis of Mouse Liver Lysosomes Provides Evidence for Mannose 6-phosphate-independent Targeting Mechanisms of Acid Hydrolases in Mucolipidosis II.
    Markmann S; Krambeck S; Hughes CJ; Mirzaian M; Aerts JM; Saftig P; Schweizer M; Vissers JP; Braulke T; Damme M
    Mol Cell Proteomics; 2017 Mar; 16(3):438-450. PubMed ID: 28062798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Modes of Balancing Glomerular Cell Proteostasis in Mucolipidosis Type II and III Prevent Proteinuria.
    Sachs W; Sachs M; Krüger E; Zielinski S; Kretz O; Huber TB; Baranowsky A; Westermann LM; Voltolini Velho R; Ludwig NF; Yorgan TA; Di Lorenzo G; Kollmann K; Braulke T; Schwartz IV; Schinke T; Danyukova T; Pohl S; Meyer-Schwesinger C
    J Am Soc Nephrol; 2020 Aug; 31(8):1796-1814. PubMed ID: 32641396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coated vesicles from rat liver and calf brain contain lysosomal enzymes bound to mannose 6-phosphate receptors.
    Campbell CH; Rome LH
    J Biol Chem; 1983 Nov; 258(21):13347-52. PubMed ID: 6138357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-Pick disease type C.
    Zhou S; Davidson C; McGlynn R; Stephney G; Dobrenis K; Vanier MT; Walkley SU
    Am J Pathol; 2011 Aug; 179(2):890-902. PubMed ID: 21708114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV.
    Boudewyn LC; Sikora J; Kuchar L; Ledvinova J; Grishchuk Y; Wang SL; Dobrenis K; Walkley SU
    Neurobiol Dis; 2017 Sep; 105():257-270. PubMed ID: 28610891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.